2025 Alz & Dementia TRCI

2025 TRCI:

Recruitment and eligibility in a Phase 1 early Alzheimer’s disease trial of Sabirnetug

File Type: 70161
Categories: 2025
Tags: INTERCEPT-AD, oligomers, Recruitment, sabirnetug, TwentyTwentyFive